中文名称 | Lisaftoclax (APG-2575; Bcl-2/Bcl-xl inhibitor 1) |
---|---|
英文名称 | (S)-N-((4-(((1,4-dioxan-2-yl)methyl)amino)-3-nitrophenyl)sulfonyl)-2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl)methyl)piperazin-1-yl)benzamide |
CAS号 | 2180923-05-9 |
分子式 | C45H48ClN7O8S |
分子量 | 882.42 |
外观 | Light yellow to yellow powder |
储存条件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Lisaftoclax (Bcl-2/Bcl-xl inhibitor 1; APG2575) is a novel and potent dual inhibitor of Bcl-2 and Bcl-xl with anticancer activity. It inhibits Bcl-2 and Bcl-xl with IC50 of 2 nM and 5.9 nM, respectively.
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft